We are pleased to highlight three recent publications from the Sucheck Group

We are pleased to highlight three recent publications from the Sucheck Group

We are pleased to highlight three recent publications from the Sucheck Group describing the synthesis and antigenicity of a Pseudomonas aeruginosa Psl pentasaccharide–CRM197 conjugate vaccine, the development of trehalose–Pks13 inhibitor conjugates targeting mycobacteria, and the discovery of benzoxazole-based Pks13 inhibitors for antimycobacterial drug discovery.

New Publication on a GPI Anchor Mimic and Application to Probing Cell Surface Signaling

A big thank you to the Karunarathne, Martin, Sprague, and Payton groups, along with their students, for making the magic happen with a glycosylphosphatidylinositol (GPI) anchor mimic prepared by our talented PhD candidate, Ms. Chloe Sebilleau. 🌟
Check out the study here: https://lnkd.in/gpK73Fh7
This work presents a novel labeling method to incorporate protein-based sensors at the cell surface of intact cells, demonstrating its application to probe cell surface signaling.

Prof. Sucheck and his collaborators Awarded NIH grant to create and study new antibacterial vaccines

In January we received an award for our multi PI grant titled “Methods to Synthesize Oligosaccharide-Fusion Protein Conjugates and Enhancement of their Antigenicity”. The scope of the project includes oligosaccharide, protein, and adjuvant synthesis. The components will combined and evaluated as antibacterial vaccines. The 2.3 million dollar grant, awarded over 5 years, supports research in the Sucheck group as well as research in the groups of Prof. Katherine Wall and Prof. Erin Prestwich.